Mechanism of molecular interaction of sitagliptin with human DPP4 enzyme - New Insights
Advances in Medical Sciences · 2023-09 · 68 (2) · 402-408
DOI: 10.1016/j.advms.2023.10.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Medical Sciences, 2023-09. Verfasst von Michelangelo Bauwelz Gonzatti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology, and Parasitology, Federal University of São Paulo, São Paulo, SP, Brazil. Hauptthemen laut MEDLINE: Dipeptidyl-Peptidase IV Inhibitors, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Dipeptidyl peptidase 4 (DPP4) inactivates a range of bioactive peptides. The cleavage of insulinotropic peptides and glucagon-like peptide 1 (GLP1) by DPP4 directly influences glucose homeostasis. This study aimed to describe the mode of interaction between sitagliptin (an antidiabetic drug) and human DPP4 using in silico approaches. MATERIALS AND METHODS: Docking studies were conducted using AutoDock Vina, 2D and 3D schematic drawings were obtained using PoseView and PLIP servers, and the DPP4-sitagliptin complex was visualized with Pymol software. RESULTS: The best affinity energy to form the DPP4-sitagliptin complex was E-value = - 8.1 kcal mol-1, as indicated by docking simulations. This result suggests a strong interaction. According to our observations, hydrophobic interactions involving the amino acids residues Tyr663 and Val712, hydrogen bonds (Glu203, Glu204, Tyr663, and Tyr667), π-Stacking interactions (Phe355 and Tyr667), and halogenic bonds (Arg123, Glu204, and Arg356) were prevalent in the DPP4-sitagliptin complex. Root Mean Square Deviation prediction also demonstrated that the global structure of the human DPP4 did not have a significant change in its topology, even after the formation of the DPP4-sitagliptin complex. CONCLUSION: The stable interaction between the sitagliptin ligand and the DPP4 enzyme was demonstrated through molecular docking simulations. The findings presented in this work enhance the understanding of the physicochemical properties of the sitagliptin interaction site, supporting the design of more efficient gliptin-like iDPP4 inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Immunology, and Parasitology, Federal University of São Paulo, São Paulo, SP, Brazil.
- Department of Biology, Federal University of Ceará, Fortaleza, CE, Brazil.
- Department of Genetics, Evolution, Immunology, and Microbiology, State University of Campinas, Campinas, SP, Brazil.
- Christus University Center, Unichristus, Fortaleza, CE, Brazil.
- Superior Institute of Biomedical Sciences, State University of Ceará, Fortaleza, CE, Brazil.
- Superior Institute of Biomedical Sciences, State University of Ceará, Fortaleza, CE, Brazil. Electronic address: jednesio@gmail.com.
Zitieren
APA
Gonzatti, M. B., Júnior, J. E. M., Rocha, A. J., de Oliveira, J. S., Evangelista, A. J. J., Fonseca, F. M. P., Ceccatto, V. M., de Oliveira, A. C., & da Cruz Freire, J. E. (2023). Mechanism of molecular interaction of sitagliptin with human DPP4 enzyme - New Insights. Advances in Medical Sciences, 68(2), 402-408. https://doi.org/10.1016/j.advms.2023.10.002
Vancouver
Gonzatti MB, Júnior JEM, Rocha AJ, de Oliveira JS, Evangelista AJJ, Fonseca FMP, et al. Mechanism of molecular interaction of sitagliptin with human DPP4 enzyme - New Insights. Advances in Medical Sciences. 2023;68(2):402-408. doi:10.1016/j.advms.2023.10.002
BibTeX
@article{Gonzatti2023,
author = {Gonzatti, Michelangelo Bauwelz and Júnior, José Edvar Monteiro and Rocha, Antônio José and de Oliveira, Jonathas Sales and Evangelista, Antônio José de Jesus and Fonseca, Fátima Morgana Pio and Ceccatto, Vânia Marilande and de Oliveira, Ariclécio Cunha and da Cruz Freire, José Ednésio},
title = {Mechanism of molecular interaction of sitagliptin with human DPP4 enzyme - New Insights},
journal = {Advances in Medical Sciences},
year = {2023},
volume = {68},
number = {2},
pages = {402--408},
doi = {10.1016/j.advms.2023.10.002}
}
EUVIMED